- Home
- IMMP vs SPOK Comparison
IMMP vs SPOK Comparison
Compare IMMP & SPOK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMMP
- SPOK
- Stock Information
- Founded
- IMMP 1987
- SPOK 2004
- Country
- IMMP Australia
- SPOK United States
- Employees
- IMMP N/A
- SPOK N/A
- Industry
- IMMP Biotechnology: Pharmaceutical Preparations
- SPOK Telecommunications Equipment
- Sector
- IMMP Health Care
- SPOK Telecommunications
- Exchange
- IMMP Nasdaq
- SPOK Nasdaq
- Market Cap
- IMMP 304.0M
- SPOK 329.2M
- IPO Year
- IMMP N/A
- SPOK 1992
- Fundamental
- Price
- IMMP $1.84
- SPOK $15.91
- Analyst Decision
- IMMP Buy
- SPOK Hold
- Analyst Count
- IMMP 2
- SPOK 1
- Target Price
- IMMP $8.50
- SPOK $15.00
- AVG Volume (30 Days)
- IMMP 82.5K
- SPOK 154.9K
- Earning Date
- IMMP 03-25-2025
- SPOK 04-30-2025
- Dividend Yield
- IMMP N/A
- SPOK 7.94%
- EPS Growth
- IMMP N/A
- SPOK N/A
- EPS
- IMMP N/A
- SPOK 0.73
- Revenue
- IMMP $3,019,249.00
- SPOK $137,653,000.00
- Revenue This Year
- IMMP N/A
- SPOK $3.51
- Revenue Next Year
- IMMP $20.28
- SPOK N/A
- P/E Ratio
- IMMP N/A
- SPOK $21.63
- Revenue Growth
- IMMP 24.11
- SPOK N/A
- 52 Week Low
- IMMP $1.65
- SPOK $13.24
- 52 Week High
- IMMP $3.34
- SPOK $17.96
- Technical
- Relative Strength Index (RSI)
- IMMP 47.21
- SPOK 37.78
- Support Level
- IMMP $1.65
- SPOK $15.52
- Resistance Level
- IMMP $1.88
- SPOK $16.86
- Average True Range (ATR)
- IMMP 0.09
- SPOK 0.48
- MACD
- IMMP 0.00
- SPOK -0.11
- Stochastic Oscillator
- IMMP 60.00
- SPOK 11.27
About IMMP Immutep Limited
Immutep Ltd is a globally active biotechnology company developing immunotherapy products for cancer and autoimmune diseases. Its main product is IMP321, which involves clinical development for the treatment of cancer indications. The company is also focused on the development of other products, which include IMP701, which is a blocking anti-LAG-3 antibody for cancer and is in Phase I of its clinical trials, and CVac, which is a personalized immunocellular therapeutic investigated for the treatment of epithelial cancer. Geographically all the business activity of the firm is functioned through the region of Australia.
About SPOK Spok Holdings Inc.
Spok Holdings Inc is a provider of healthcare communications. It reports three market segments namely Healthcare, Government, and Large enterprise. The company provides paging services and software solutions in the United States and abroad. It provides services such as Value-Added Services, Advisory Services, Assessment Services and Adoption Services.